Damon Runyon identifies today’s most brilliant early career scientists and funds their innovative cancer research.

Meelad M. Dawlaty, PhD
Dr. Dawlaty is establishing the significance of epigenetic alterations (chemical modifications of DNA) in brain cancer formation, or glioblastomagenesis. The goal of his research is to determine the role of epigenetic changes in glioblastomagenesis.
Project Title: "Deciphering the genetics and epigenetics of glioblastomagenesis by direct in vitro reprogramming of glioblastoma multiforme progenitor cells"
Institution: Whitehead Institute for Biomedical Research
Sponsor(s) / Mentor(s): Rudolf Jaenisch, MD
Cancer Type: Neuro-oncology
Research Area: Epigenetics



